Reply to the research mission in myeloma by Richardson et al.

被引：0
|
作者：
Bergsagel, P. L. [1 ]
机构：
[1] Mayo Clin, Ctr Canc, Scottsdale, AZ USA
来源：
LEUKEMIA | 2009年 / 23卷 / 02期
关键词：
LENALIDOMIDE PLUS DEXAMETHASONE; MELPHALAN-PREDNISONE MP; MULTIPLE-MYELOMA; CELL TRANSPLANTATION; ELDERLY-PATIENTS; DOUBLE-BLIND; THALIDOMIDE; BORTEZOMIB; THERAPY; PHASE-3;
D O I：
10.1038/leu.2008.211
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：423 / 424
页数：3
相关论文
共 50 条
  • [31] Shishkov et al. Reply
    Shishkov, V. Yu
    Andrianov, E.S.
    Pukhov, A.A.
    Vinogradov, A.P.
    Lisyansky, A.A.
    1600, American Physical Society (124):
  • [32] Reply to Munhoz et al.
    Hisamitsu Zaha
    Norie Abe
    Noriko Sagawa
    Mikiko Unesoko
    Breast Cancer Research and Treatment, 2017, 163 (2) : 411 - 412
  • [33] Casini et al. reply
    Casini, G.
    Maurenzig, P.R.
    Olmi, A.
    Bini, M.
    Calamai, S.
    Meucci, F.
    Pasquali, G.
    Poggi, G.
    Stefanini, A.A.
    Gobbi, A.
    Hildenbrand, K.D.
    Physical Review Letters, 1997, 79 (17)
  • [34] Reply to Ballard et al.
    Wallis, J. P.
    Wells, A. W.
    Chapman, C. E.
    TRANSFUSION MEDICINE, 2007, 17 (04) : 317 - 317
  • [35] Reply to Katsumi et al.
    J Pannek
    Spinal Cord, 2011, 49 (10) : 1086 - 1086
  • [36] Matias et al. reply
    Matias, M.A.
    Perez-Munuzuri, V.
    Perez-Villar, V.
    Physical Review Letters, 1998, 80 (13):
  • [37] Buckeridge et al. Reply
    Buckeridge, J.
    Catlow, C.R.A.
    Scanlon, D.O.
    Keal, T.W.
    Sherwood, P.
    Miskufova, M.
    Walsh, A.
    Woodley, S.M.
    Sokol, A.A.
    Physical Review Letters, 2015, 115 (02)
  • [38] Kim et al. reply
    Kim S.
    Jin J.
    Kim Y.-J.
    Park I.-Y.
    Kim Y.
    Kim S.-W.
    Nature, 2012, 485 (7397) : E1 - E3
  • [39] Reply to Ross et al.
    D Steinbach
    K-M Debatin
    Leukemia, 2009, 23 (4) : 820 - 820
  • [40] Balasubramanian et al. Reply
    Balasubramanian, Venkat
    Buchel, Alex
    Green, Stephen R.
    Lehner, Luis
    Liebling, Steven L.
    PHYSICAL REVIEW LETTERS, 2015, 115 (04)
12345